 
 
GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                                                                Synonyms: AVI | Emblaveo® (aztreonam and avibactam) | NXL 104 | NXL-104 | NXL104
                                 avibactam is an approved drug (FDA (2015), EMA (2016)) Compound class: 
                                                            Synthetic organic
                                 
                                    
                                        Comment: Avibactam (NXL104) is non-β-lactam β-lactamase inhibitor [1]. It has activity against class A and C serine β-lactamases, including Klebsiella pneumoniae carbapenemases.
                                    
                                 | 
 | |||||||||||||||||||||||||||||||||||
| No information available. | 
| Summary of Clinical Use  | 
| Avibactam is used in fixed-dose formulations with the cephalosporin ceftazidime (Zavicefta®, approved by the EMA in 2016 and Avycaz®, FDA approval in 2015). These drugs are used to treat complicated intra-abdominal infection, kidney infections, pneumonia and urinary tract infection caused by gram-negative bacteria. |